首页> 外国专利> 1,2,3,4-tetrahydronaphthalene and 1,2,3,4-tetrahydro-2-naphthalenol derivatives and pharmaceuticals thereof, and their use as potassium channel inhibitors useful for treating cardiac arrhythmias

1,2,3,4-tetrahydronaphthalene and 1,2,3,4-tetrahydro-2-naphthalenol derivatives and pharmaceuticals thereof, and their use as potassium channel inhibitors useful for treating cardiac arrhythmias

机译:1,2,3,4-四氢萘和1,2,3,4-四氢-2-萘酚衍生物及其药物,以及它们作为可用于治疗心律不齐的钾通道抑制剂的用途

摘要

A compound of formula (I), wherein: t is 1, or 2; A and B are each H; or taken together form a bond between the substituted carbons. R1 is H; alkyl; or is optionally substituted aryl, heteroaryl, heterocyclyl or carbocycloalkyl, with the proviso that when R1 is an optionally substituted aryl, then R1 is not a dialkoxyphenyl. Y2 is (CH2)q; (CH2)wO; HC=CH; or ethynyl; with the proviso that if Y2 is (CH2)q and q=0, then R1 cannot be H. X2 is C=0, C=S, or S02; with the proviso that if Y2 is (CH2)wO, then X2 is not SO2. R3 is H; alkyl; or optionally substituted aryl, aralkyl, heteroaryl, heteroaralkyl; heterocyclyl, carbocycloalkyl; or an alkylene-(substituted amino). Z is H; alkyl; alkyenyl; alkylene(heterocyclyl); alkylene (heteroaryl); alkylene-NHC(O)(alkyl); alkylene-NHC(O)(aryl); alkylene-NHC(O)(heterocyclyl); alkylene-NHC(O)(heteroaryl); alkylene-NHC(O)-(alkylene-heterocyclyl); alkylene-NHC(O)-(heteroaralkyl); alkylene-C(O)(alkyl); alkylene-C(O)O(alkyl); OR14; SR14; or NR15R16. R2 is H; alkyl; optionally substituted aryl, aralkyl, heteroaryl, heterocyclyl, heteroaralkyl, carbocycloalkyl; Ra-O-; or RbRc-N-. Y1 is (CH2)p; CHR17(CH2)o; HC=CH; or ethynyl; X1 is C=O; C=S; SO2; or (CH2)n. R4 is H; alkyl; optionally substituted aryl, aralkyl, heteroaryl, heteroaralkyl; heterocyclyl, carbocycloalkyl; or alkylene-(substituted amino). With the provisos that: (i) If Y1 is (CH2)p, p is 0 and X1 is not (CH2)n then R2 is not H, (ii) If R2 is Ra-O and Y1 is (CH2)p with p=0, then X1 is not SO2 and (iii) If Z is not H, OR14, SR14 or NR15R16, then X2 must be SO2. Also described is a pharmaceutical composition comprising the compound of formula (I) and a pharmaceutically acceptable diluent or carrier. The compounds of formula (I) are useful for inhibiting potassium transport across cellular membranes possessing potassium channels. The compounds of formula (I) are particularly useful for treating cardiac arrhythmias.
机译:式(I)的化合物,其中:t为1或2; A和B分别为H;或一起形成取代碳之间的键。 R1是H;烷基;或为任选取代的芳基,杂芳基,杂环基或碳环烷基,条件是当R1为任选取代的芳基时,则R1不是二烷氧基苯基。 Y2为(CH2)q; (CH2)wO; HC = CH;或乙炔基;前提是如果Y2为(CH2)q并且q = 0,则R1不能为H。X2为C = 0,C = S或S02;前提是如果Y2为(CH2)wO,则X2不是SO2。 R3为H;烷基;或任选取代的芳基,芳烷基,杂芳基,杂芳烷基;杂环基,碳环烷基;或亚烷基-(取代的氨基)。 Z为H;烷基;炔基亚烷基(杂环基);亚烷基(杂芳基);亚烷基-NHC(O)(烷基);亚烷基-NHC(O)(芳基);亚烷基-NHC(O)(杂环基);亚烷基-NHC(O)(杂芳基);亚烷基-NHC(O)-(亚烷基-杂环基);亚烷基-NHC(O)-(杂芳烷基);亚烷基-C(O)(烷基);亚烷基-C(O)O(烷基); OR14; SR14;或NR15R16。 R2为H;烷基;任选取代的芳基,芳烷基,杂芳基,杂环基,杂芳烷基,碳环烷基; Ra-O-;或RbRc-N-。 Y1为(CH2)p; CHR17(CH2)o; HC = CH;或乙炔基; X1是C = O; C = S;二氧化硫或(CH2)n。 R4为H;烷基;任选取代的芳基,芳烷基,杂芳基,杂芳烷基;杂环基,碳环烷基;或亚烷基-(取代的氨基)。满足以下条件:(i)如果Y1为(CH2)p,p为0且X1不是(CH2)n,则R2不为H,(ii)如果R2为Ra-O且Y1为(CH2)p p = 0,则X1不是SO2;(iii)如果Z不是H,OR14,SR14或NR15R16,则X2必须是SO2。还描述了包含式(I)的化合物和药学上可接受的稀释剂或载体的药物组合物。式(I)化合物可用于抑制钾穿过具有钾通道的细胞膜的转运。式(I)的化合物特别用于治疗心律不齐。

著录项

  • 公开/公告号NZ505666A

    专利类型

  • 公开/公告日2002-11-26

    原文格式PDF

  • 申请/专利权人 ICAGEN INC;

    申请/专利号NZ19990505666

  • 发明设计人 GROSS MICHAEL F;CASTLE NEIL A;

    申请日1999-01-27

  • 分类号C07C311/20;C07C311/13;C07C311/29;C07D207/16;C07D213/56;C07D213/44;C07D217/26;C07D333/38;A61K31/18;A61K31/36;A61K31/472;A61K31/381;A61K31/4406;A61K31/4409;A61K31/4402;A61K31/40;A61K31/47;A61K31/445;A61K31/444;C07D333/34;C07D217/02;C07D317/60;C07D215/04;C07D211/60;C07D211/62;C07D401/12;

  • 国家 NZ

  • 入库时间 2022-08-22 00:01:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号